Clinical Trial Update: HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of HLX07+HLX10 with chemotherapy or HLX07 monotherapy in advanced/metastatic gastric/gastroesophageal junction cancer is in progress with u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• HLX07 (HLX07)
• HLX10

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) | Phase 2 | Status: UNKNOWN